Klaus Herfarth

9.8k total citations
275 papers, 6.9k citations indexed

About

Klaus Herfarth is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Klaus Herfarth has authored 275 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Pulmonary and Respiratory Medicine, 107 papers in Radiation and 67 papers in Surgery. Recurrent topics in Klaus Herfarth's work include Advanced Radiotherapy Techniques (105 papers), Radiation Therapy and Dosimetry (61 papers) and Glioma Diagnosis and Treatment (38 papers). Klaus Herfarth is often cited by papers focused on Advanced Radiotherapy Techniques (105 papers), Radiation Therapy and Dosimetry (61 papers) and Glioma Diagnosis and Treatment (38 papers). Klaus Herfarth collaborates with scholars based in Germany, United States and Switzerland. Klaus Herfarth's co-authors include Jürgen Debus, Matthias Uhl, Florian Sterzing, M. Wannenmacher, Holger Hof, Malte L. Bahner, Frank Lohr, Angelika Höss, Bernhard Rhein and Wolfgang Schlegel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Klaus Herfarth

266 papers receiving 6.8k citations

Peers

Countries citing papers authored by Klaus Herfarth

Since Specialization

Citations

This map shows the geographic impact of Klaus Herfarth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Herfarth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Herfarth more than expected).

Fields of papers citing papers by Klaus Herfarth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Herfarth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Herfarth. The network helps show where Klaus Herfarth may publish in the future.

Co-authorship network of co-authors of Klaus Herfarth

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Herfarth. A scholar is included among the top collaborators of Klaus Herfarth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Herfarth. Klaus Herfarth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancer 2025 ·Radiation Oncology ·(unknown), (unknown), (unknown), Fabian Weykamp, Katharina Seidensaal, Christoph Springfeld, Michael T. Dill, Thomas Longerich, Peter Schirmacher, Arianeb Mehrabi, (unknown), Bruno Köhler, Jürgen Debus, Klaus Herfarth, Jakob Liermann	1
2	Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro 2024 ·Cancers ·(unknown), Thomas Tessonnier, Ivana Đokić, Stephan Brons, Bouchra Tawk, Andrea Mairani, Amir Abdollahi, Jürgen Debus, Klaus Herfarth, Jakob Liermann	1
3	TOWARDS DAILY ONLINE MR-IMAGE-GUIDED PARTICLE THERAPY: FIRST CLINICAL APPLICATION OF A SHUTTLE-BASED WORKFLOW AT THE HEIDELBERG ION-BEAM THERAPY CENTER 2024 ·International Journal of Particle Therapy ·Julia Bauer, (unknown), (unknown), M. Ellerbrock, T. Hansmann, Sebastian Klüter, Sabine Kühn, Jakob Liermann, Katharina Paul, Marcus Winter, Thomas Haberer, Klaus Herfarth, Jürgen Debus, Katharina Seidensaal	1
4	Bone Marrow Sparing by Intensity Modulated Proton Beam Therapy in Postoperative Irradiation of Gynecologic Malignancies 2024 ·Technology in Cancer Research & Treatment ·(unknown), Anil Gupta, Eva Meixner, Laila König, Juliane Hörner‐Rieber, Tobias Förster, Kristin Lang, M. Ellerbrock, Klaus Herfarth, Jürgen Debus, Nathalie Arians	3
5	Pelvic Irradiation for Node-Positive Prostate Cancer After Prostatectomy: Long-Term Results of the Prospective PLATIN-4 and PLATIN-5 Trials 2023 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), (unknown), (unknown), Jakob Liermann, Arndt‐Christian Müller, Daniel Zips, Jürgen Debus, Klaus Herfarth, Stefan A. Koerber	5
6	Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial 2023 ·Radiation Oncology ·Eva Meixner, (unknown), Tobias Förster, Fabian Weykamp, Kristin Lang, Laila König, Katja Lindel, (unknown), Johannes Krisam, Andreas Schneeweiß, M. Ellerbrock, (unknown), Juliane Hörner‐Rieber, Klaus Herfarth, Jürgen Debus, Nathalie Arians	7
7	Combined Photon and Carbon Ion Radiation Therapy for Sinonasal Malignancies: Results of the HIT–SNT Prospective Phase 2 Trial 2023 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Thomas Held, Kristin Lang, (unknown), Semi Harrabi, (unknown), Christian Freudlsperger, Klaus Herfarth, Jürgen Debus, Thomas Haberer, Marc Münter, Alexandra D Jensen, Sebastian Adeberg	0
8	Radiotherapy with Helium Ions Has the Potential to Improve Both Endocrine and Neurocognitive Outcome in Pediatric Patients with Ependymoma 2022 ·Cancers ·(unknown), Thomas Tessonnier, Maximilian Deng, Sebastian Adeberg, Katharina Seidensaal, (unknown), Jürgen Debus, Klaus Herfarth, Semi Harrabi	7
9	Outcome after Radiotherapy for Vestibular Schwannomas (VS)—Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton Therapy 2022 ·Cancers ·(unknown), Rami A. El Shafie, Sebastian Adeberg, Klaus Herfarth, Laila König, Kristin Lang, Juliane Hörner‐Rieber, Peter K. Plinkert, Wolfgang Wick, Felix Sahm, (unknown), Jürgen Debus, Denise Bernhardt	5
10	Intensity Modulated Radiotherapy with Carbon Ion Radiotherapy Boost for Acinic Cell Carcinoma of the Salivary Glands 2021 ·Cancers ·Maximilian Schmid, Thomas Held, Kristin Lang, Klaus Herfarth, Juliane Hörner‐Rieber, Semi Harrabi, Julius Moratin, Christian Freudlsperger, Karim Zaoui, Jürgen Debus, Sebastian Adeberg	0
11	Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil 2021 ·Strahlentherapie und Onkologie ·Tanja Eichkorn, (unknown), Sebastian Regnery, Rami A. El Shafie, Juliane Hörner‐Rieber, Sebastian Adeberg, Klaus Herfarth, Jürgen Debus, Laila König	5
12	Neurocognitive Outcomes in Pediatric Patients Following Brain Irradiation 2021 ·Cancers ·(unknown), (unknown), Sebastian Regnery, Laila König, Denise Bernhardt, Olaf Witt, Klaus Herfarth, Andreas Unterberg, Christine Jungk, (unknown), Stephanie E. Combs, Jürgen Debus, Stefan Rieken, Semi Harrabi, Sebastian Adeberg	18
13	Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial 2020 ·Radiation Oncology ·Thomas Held, Kristin Lang, Sebastian Regnery, (unknown), (unknown), (unknown), Eric Tonndorf‐Martini, Johannes Krisam, Peter K. Plinkert, Karim Zaoui, Christian Freudlsperger, Julius Moratin, Jürgen Krauß, Semi Harrabi, Klaus Herfarth, Jürgen Debus, Sebastian Adeberg	10
14	Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy 2019 ·Acta Oncologica ·Camilla H. Stokkevåg, Daniel J. Indelicato, Klaus Herfarth, Henriette Magelssen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Helge Egil Seime Pettersen, Marianne Brydøy, Petter Brandal, L.P. Muren	13
15	Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control 2019 ·Cancers ·Sati Akbaba, Thomas Held, Kristin Lang, Tobias Förster, P. Federspil, Klaus Herfarth, Matthias Häfner, Peter K. Plinkert, Stefan Rieken, Jürgen Debus, Sebastian Adeberg	15
16	Dose-Limiting Organs at Risk in Carbon Ion Re-Irradiation of Head and Neck Malignancies: An Individual Risk-Benefit Tradeoff 2019 ·Cancers ·Thomas Held, Semi Harrabi, Kristin Lang, Sati Akbaba, Paul Windisch, Denise Bernhardt, Stefan Rieken, Klaus Herfarth, Jürgen Debus, Sebastian Adeberg	6
17	The impact of age on the outcome of patients treated with radiotherapy for mucoepidermoid carcinoma (MEC) of the salivary glands in the head and neck: A 15-year single-center experience 2019 ·Oral Oncology ·Sati Akbaba, (unknown), Andreas Möck, Thomas Held, Kristin Lang, (unknown), Tobias Förster, Sonja Katayama, Steffen Kargus, Stefan Rieken, Peter K. Plinkert, Klaus Herfarth, Jürgen Debus, Sebastian Adeberg	8
18	Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions 2019 ·Radiation Oncology ·Thomas Held, Paul Windisch, Sati Akbaba, Kristin Lang, (unknown), Jakob Liermann, Denise Bernhardt, Peter K. Plinkert, Christian Freudlsperger, Stefan Rieken, Klaus Herfarth, Jürgen Debus, Sebastian Adeberg	5
19	Treatment Outcome of 227 Patients with Sinonasal Adenoid Cystic Carcinoma (ACC) after Intensity Modulated Radiotherapy and Active Raster-Scanning Carbon Ion Boost: A 10-Year Single-Center Experience 2019 ·Cancers ·Sati Akbaba, (unknown), Andreas Möck, Thomas Held, (unknown), Kristin Lang, Mustafa Syed, (unknown), Tobias Förster, P. Federspil, Klaus Herfarth, Peter K. Plinkert, Jürgen Debus, Sebastian Adeberg	21
20	Oncogene addiction and radiation oncology: effect of radiotherapy with photons and carbon ions in ALK-EML4 translocated NSCLC 2018 ·Radiation Oncology ·Ying Dai, (unknown), Christian Schwager, Janina Hanne, Cheng Zhou, Klaus Herfarth, Stefan Rieken, Kenneth E. Lipson, Jürgen Debus, Amir Abdollahi	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact